Received: 28 September 2018
Accepted: 3 February 2019
First Online: 27 February 2019
Ethics approval and consent to participate
: The Regional Ethics Committee for Medical Research in Norway (S-02216) and the Norwegian Data Inspectorate (2002/1934) approved the study. Written informed consent was obtained from each participant prior to enrollment.
: Not applicable.
: In the interest of full disclosure of what may be perceived or potential competing financial interests, the authors R.K., A.G., and S.J. declare that they have been partially supported by a grant from the United States National Institute of Health R01 DK 110793-01 and the Gerber Foundation titled “Effects of Human Milk Oligosaccharides on the Developing Infant Gut Microbiome and Adiposity Changes in Early Infancy.” Furthermore, RK is on the Scientific Advisory Board for Commense Inc. Commense is pioneering a deep understanding of the microbiome early in life and its fundamental role in promoting a lifetime of health. Drawing insights from natural exposures to beneficial microbes, Commense is developing approaches to guide the priming, seeding and maintaining of the microbiome in infants and children. The remaining authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.